Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Bio Gene Therapeutics announced it raised $250,000 in an initial filing from an offering of $250,000

PRIVATEAug 06, 2026•3 days ago

Amount Raised

$250,000

Round Type

Venture - Series Unknown

VancouverBiotechnologyHealth Care

Company Information

Company

BioGene Therapeutics

Location

Vancouver, British Columbia, Canada

About

BioGene Therapeutics Inc. is a life sciences company focused on advancing innovative therapies in metabolic health and gene-based treatments. The company is a subsidiary of PreveCeutical Medical Inc. and aims to tackle challenging problems in drug discovery.

Predictive Intelligence
Strategic

ML-powered predictions for BioGene Therapeutics's next move

Learn about Strategic plan

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.